Skip To Content

Study ID: Abbott Absorb IV 10-392

Title:

Abbott Absorb IV 10-392 ABSORB IV Randomized Controlled Trial, A Clinical Evaluation of Absorb BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects with de novo Native Coronary Artery Lesions.

Location:
Sioux Falls Region
Principal Investigator:
Tomasz Stys, MD
Disease:
Heart
Stage:
IDE
Status:
Active - Open to Accrual

For more information, call or email Bismarck Clinical Research at (701) 323-5760, Fargo and Bemidji Clinical Research at (701) 234-5890, or Sioux Falls Clinical Research at (605) 328-1368.